Pharma / Biotech

Baxdela Gets CABP Indication

The FDA approval of the new indication is based on positive results from a phase 3, randomized, double-blind study that compared the efficacy and safety of delafloxacin with moxifloxacin.

Source link

Related posts

XYLOCAINE (lidocaine hydrochloride) injection, solution [General Injectables & Vaccines, Inc]


IV Insulin Infusions: Is Variation the Enemy Of Quality and Safety?


PROVERA (Medroxyprogesterone Acetate) Tablet [Pharmacia And Upjohn Company LLC]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy